Ixaka, an integrated cell and gene therapy company, says that Advanced Therapy Medicinal Product (ATMP) classification has been granted by the European Medicines Agency (EMA) for its Chemically Encapsulated Lentiviral vector for Targeted In Vivo CAR T-cell therapy (CELTIC-19) targeted nanoparticle (TNP) product.
Olympus Corporation has completed the separation of its Scientific Solutions business to a wholly-owned subsidiary, Evident Corporation. Following the divestiture of its Imaging business, this move further signifies the company’s long-term strategy to cement its position as a major player in the medtech industry.
Vygon, a specialist single-use medical devices group, has acquired Macatt Medica, a distribution company located in Lima, Peru. The company distributes the majority of Vygon’s products in Peru, including a wide range of enteral nutrition products. The financial terms of the agreement have not been disclosed.
Registration is now open for the International Hospital Federation’s 45th World Hospital Congress, taking place on 9–11 November 2022 at the Dubai International Convention & Exhibition Centre (DWTC), UAE.
Headaches such as migraine are among the leading causes of morbidity worldwide, but most treatments provide only partial relief. While scientists know that migraine and related headaches are caused by activity in a part of the nervous system known as the trigeminal ganglion (TG), it remains unclear which genes and cell types of the TG are […]
Mayo Clinic researchers have proposed a new model for mapping the symptoms of Alzheimer’s disease to brain anatomy. This model was developed by applying machine learning to patient brain imaging data. It uses the entire function of the brain rather than specific brain regions or networks to explain the relationship between brain anatomy and mental […]
French company CardioRenal, which specializes in improving treatment at home for patients with severe chronic kidney disease, has secured €3.3 million from business angels and longstanding company shareholders as part of a round of seed capital financing.
Medical equipment made using Solvay’s Udel high-performance polysulfone (PSU) thermoplastic will be recycled at the end of their useful lives in a new sustainability initiative that the company has embarked on with Mitsubishi Chemical Advanced Materials (MCAM).
Volastra Therapeutics, an oncology company focused on exploiting chromosomal instability (CIN) as a vulnerability for cancer cells, will collaborate with Bristol Myers Squibb to discover, develop and commercialize new medicines.
French company Ubiplug, a designer and developer of medical devices to enhance the healthcare of patients undergoing vascular access procedures, has obtained ISO 13485:2016 certification for its Quality Management System (QMS).
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
